🇺🇸 Phosphate Binder in United States

13 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nausea — 3 reports (23.08%)
  2. Abdominal Pain — 2 reports (15.38%)
  3. Application Site Pain — 1 report (7.69%)
  4. Arthritis — 1 report (7.69%)
  5. Azotaemia — 1 report (7.69%)
  6. Blood Phosphorus Increased — 1 report (7.69%)
  7. Blood Potassium Increased — 1 report (7.69%)
  8. Blood Thyroid Stimulating Hormone Increased — 1 report (7.69%)
  9. Cardiac Disorder — 1 report (7.69%)
  10. Cardiac Failure Acute — 1 report (7.69%)

Source database →

Phosphate Binder in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Phosphate Binder approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Phosphate Binder in United States?

Assiut University is the originator. The local marketing authorisation holder may differ — check the official source linked above.